Remote Monitoring Portfolio™ Patient Care Network (PCN)

Portfolio Overview

  • Enabling early clinical intervention
  • Improving clinical outcomes1
  • Delivering efficient and comprehensive care
  • Addressing population health management and reducing health care costs2

Reduced Risk, Reduced Mortality5,6

Activating a remote transmitter can more than double a patient’s probability of survival.5,6 

In patients implanted with a PM [pacemaker] capable of remote wireless data transmission… in-office PM setup was associated with a significantly higher rate of successful transmission.10

Proactive Care and Convenience

With remote monitoring, data automation and alerts, you can replace in-office visits with more efficient remote follow-ups and gain the opportunity to make more timely clinical interventions. Overall, remote monitoring is convenient for both you and your patients.

  • Patient convenience: Distance to the hospital makes frequent in-person evaluations of devices difficult, especially when increasingly frequent follow-ups are needed, e.g., near the end of a device’s battery life. Remote follow-ups let patients avoid difficult and expensive travel.7,8
  • Clinician convenience: Remote monitoring saves you and your staff time without lowering patient satisfaction, even if the number of patients with devices increases.7,8

Our wireless remote monitoring, with the™ Patient Care Network (PCN) and Merlin@home™ Transmitter, works with our featured defibrillators and pacemakers, including the Assurity MRI™ pacemaker.

Improved Quality of Care

Remote monitoring enables early diagnosis of technical or clinical issues, which facilitates early clinical intervention if needed. Clinical benefits, as seen in clinical trials, include:

  • 79% reduction in time to detection of clinical events3
  • 66% reduction in hospitalizations for atrial arrhythmia and related stroke3
  • 50% reduction in relative risk of death1
  • 34% reduction in all-cause mortality over 3 years for ICD/CRT-D patients2
  • 27% reduction in all-cause mortality over 3 years2

Activating a remote transmitter can more than double a patient’s probability of survival,5,6 and patients with the highest adherence to remote monitoring have seen the highest probability of survival.2,5,6  You can begin monitoring your patient immediately after a device is implanted, and such use is crucial to realizing the full value of a remote monitoring system.

We have especially strong clinical evidence showing the benefits of remote monitoring in early stroke intervention.

See clinical evidence

Remote Monitoring With the CardioMEMS™ HF System

Our remote monitoring is not restricted to cardiac arrhythmia management. We also offer the CardioMEMS™ HF System, which is the first and only FDA-approved wireless heart failure (HF) monitor and accurately measures pulmonary artery pressure.

Learn more about the CardioMEMS HF System.

Components of the CardioMEMS™ HF System

Economic Evidence

At Abbott, we are dedicated to improving clinical outcomes while also reducing health care costs. Remote monitoring is a critical tool in population health management and addresses disease states that contribute greatly to high health care costs, including atrial fibrillation and heart failure.

Remote monitoring starts working from day one and can lower health care costs by reducing:

  • The number of in-hospital device evaluations9
  • The number of hospital admissions3
  • The length of stay per cardiac hospitalization3
  • Potential follow-up office visits9

See economic evidence

A Leader in the Advancement of Cardiac Arrhythmia Management

At Abbott, we provide a full range of electrophysiology and cardiac rhythm management solutions designed to enable diagnosis and treatment of arrhythmias and streamline workflows. We offer therapy solutions to help you improve patient management for various arrhythmias, from the less serious to the most frequently fatal.

Learn more about our approach to cardiac arrhythmia management.

Drawing of heart diagram with parts of the heart labeled a-i

1. Saxon, L. A., Hayes, D. L., Gilliam, F. R., Heidenriech, P. A., Day, J., Seth, M., … Boehmer, J. P. (2010). Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. Circulation, 122, 2359-2367.
2. Crossley, G. H., Boyle, A., Vitense, H., Chang, Y., Mead, R. H., & CONNECT Investigators. (2011). The CONNECT (Clinical Evaluation of Remote Notification to Re-duce Time to Clinical Decision) trial: The value of wireless remote monitoring with automatic clinician alerts. Journal of the American College of Cardiology, 57(10), 1181-1189. 
3. Mabo, P., Victor, F., Bazin, P., Ahres, S., Babuty. D., Da Costa, A., ... Dauber, J. C., & COMPAS Trial Investigators. (2012). COMPAS Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). European Heart Journal, 33, 1105-1111. 
4. Sutton, B., Zigler, J., Gopinathannair, R., Deam, G., & Graver, R. (2013). Improved health outcomes and cost-savings with remote monitoring of cardiac implantable electronic devices. Presented at the meeting of the Heart Rhythm Society, Denver, CO. Retrospective claims analysis of Medicare 5% sample Limited Data Set Standard Analytical Files claims and enrollment data across all manufacturers.
5. Mittal, S., Piccini, J., Fischer, A., Snell, J., Dalal, N., & Varma, N. (2014, May). Remote monitoring of ICD patients is associated with reduced mortality irrespective of device type. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA. This was a retrospective data review and had limitations.
6. Mittal, S., Piccini, J., Fischer, A., Snell, J., Dalal, N., & Varma, N. (2014, May). Increased adherence to remote monitoring is associated with reduced mortality in both pacemaker and defibrillator patients. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA. This was a retrospective data review and has limitations.
7. Masella, C., Zanaboni, P., Di Stasi, F., Gilardi, S., Ponzi, P., & Valsecchi, S. (2008). Assessment of a remote monitoring system for implantable cardioverter defibrillators. Journal of Telemedicine and Telecare, 14, 290-294.
8. Marzegalli, M., Lunati, M., Landolina, M., Perego, G. B., Ricci, R. P., Guenzati, G., ... Schirru, M. (2008). Remote monitoring of CRT–ICD: The multicenter Italian CareLink evaluation—ease of use, acceptance, and organizational implications. Pacing and Clinical Electrophysiology, 31, 1259-1264.
9. Varma, N., Epstein, A. E., Irimpen, A., Schweikert, R., Love, C., & TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverter defibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) trial. Circulation, 122, 325-332.
10. Ren,  X., Apostolakos, C., Vo, T. H., Shar, R. E., Shields, K., Banki, N. M., ... Goldschlager, N. F. (2012). Remote monitoring of implantable pacemakers: In-office setup significantly improves successful data transmission. Clinical Cardiology, 36(10), 634-637.

Orange 24 surrounded by headset, represents "Place an order"

Contact Customer Service

Our customer service experts can help with your product orders or questions.